Open Government Portal
About this information
Open data is defined as structured data that is machine-readable, freely shared, used and built on without restrictions.
The key things to remember about open data are:
- #Availability and access#: the data must be available as a whole and at no more than a reasonable reproduction cost, preferably by downloading over the internet. The data must also be available in a convenient and modifiable form.
- #Re-use and redistribution#: the data must be provided under terms that permit re-use and redistribution including the intermixing with other datasets.
- #Universal participation#: everyone must be able to use, re-use and redistribute. There should be no discrimination against fields of endeavour or against persons or groups. For example, 'non-commercial' restrictions that would prevent 'commercial' use, or restrictions of use for certain purposes (e.g. only in education), are not allowed.
Depending on its ingredients, a dental plaque-disclosing product can be regulated as a drug under the F&DA either as a …
Health Canada is pleased to announce the adoption of the ICH guidance E16: Biomarkers Related to Drug or Biotechnology Product …
The Access to Information Act (the Act) gives Canadian citizens, permanent residents and all individuals and corporations present in Canada …
Given the fast pace of innovation in digital health technologies specifically in relation to medical devices, Health Canada is undertaking …
Health Canada has implemented the International Council for Harmonisation of Technical Requirements of Pharmaceuticals for Human Use (ICH) Guidance: E2D …
Health Canada is initiating the transition from its current medical device categorization method to the Global Medical Device Nomenclature (GMDN), …
In agreeing to apply the Canada-European Union Comprehensive Economic and Trade Agreement (CETA), Canada has committed to provide up to …
This guidance was developed by the appropriate ICH Expert Working Group and was subject to consultation by the regulatory parties, …
This guidance has been developed by the appropriate ICH Expert Working Group and has been subject to consultation by the …
The purpose of this guidance document is to provide manufacturers of Class IV Human Immunodeficiency Virus (HIV) rapid diagnostic tests …